Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 21.63
(-0.18%)
CNY 21.63
(-0.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.01 Billion CNY | 21.7% |
| 2022 | 825.49 Million CNY | -11.12% |
| 2021 | 928.8 Million CNY | 41.8% |
| 2020 | 655 Million CNY | -44.37% |
| 2019 | 1.17 Billion CNY | 3.08% |
| 2018 | 1.14 Billion CNY | 3.52% |
| 2017 | 1.1 Billion CNY | 14.78% |
| 2016 | 961.37 Million CNY | 9.58% |
| 2015 | 877.34 Million CNY | 13.08% |
| 2014 | 775.85 Million CNY | 6.6% |
| 2013 | 727.83 Million CNY | 22.22% |
| 2012 | 595.51 Million CNY | 25.32% |
| 2011 | 475.21 Million CNY | 38.57% |
| 2010 | 342.93 Million CNY | 39.83% |
| 2009 | 245.25 Million CNY | 53.88% |
| 2008 | 159.38 Million CNY | 72.32% |
| 2007 | 92.49 Million CNY | 167.66% |
| 2006 | 34.55 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 264.75 Million CNY | -5.75% |
| 2024 Q2 | 327.27 Million CNY | 23.62% |
| 2024 Q3 | 342.78 Million CNY | 4.74% |
| 2023 Q1 | 207.34 Million CNY | -30.45% |
| 2023 Q3 | 252.79 Million CNY | -6.53% |
| 2023 FY | 1 Billion CNY | 21.7% |
| 2023 Q4 | 280.89 Million CNY | 11.12% |
| 2023 Q2 | 270.46 Million CNY | 30.45% |
| 2022 FY | 825.49 Million CNY | -11.12% |
| 2022 Q4 | 298.13 Million CNY | 59.64% |
| 2022 Q3 | 186.75 Million CNY | 3.7% |
| 2022 Q2 | 180.08 Million CNY | 12.19% |
| 2022 Q1 | 160.51 Million CNY | -46.64% |
| 2021 Q3 | 149.29 Million CNY | -53.84% |
| 2021 Q2 | 323.4 Million CNY | 108.21% |
| 2021 Q1 | 155.32 Million CNY | 125.31% |
| 2021 FY | 928.8 Million CNY | 41.8% |
| 2021 Q4 | 300.78 Million CNY | 101.47% |
| 2020 Q2 | 297.45 Million CNY | 454.08% |
| 2020 Q3 | 234.92 Million CNY | -21.02% |
| 2020 Q4 | 68.93 Million CNY | -70.66% |
| 2020 FY | 655 Million CNY | -44.37% |
| 2020 Q1 | 53.68 Million CNY | -87.3% |
| 2019 Q2 | 441.16 Million CNY | 480.99% |
| 2019 FY | 1.17 Billion CNY | 3.08% |
| 2019 Q4 | 422.61 Million CNY | 77.8% |
| 2019 Q3 | 237.68 Million CNY | -46.12% |
| 2019 Q1 | 75.93 Million CNY | 0.0% |
| 2018 FY | 1.14 Billion CNY | 3.52% |
| 2017 FY | 1.1 Billion CNY | 14.78% |
| 2016 FY | 961.37 Million CNY | 9.58% |
| 2015 FY | 877.34 Million CNY | 13.08% |
| 2014 FY | 775.85 Million CNY | 6.6% |
| 2013 Q1 | 155.91 Million CNY | 5.84% |
| 2013 Q2 | 177.22 Million CNY | 13.66% |
| 2013 Q3 | 198.69 Million CNY | 12.12% |
| 2013 FY | 727.83 Million CNY | 22.22% |
| 2012 Q2 | 134.43 Million CNY | -7.17% |
| 2012 FY | 595.51 Million CNY | 25.32% |
| 2012 Q4 | 147.31 Million CNY | -12.8% |
| 2012 Q3 | 168.94 Million CNY | 25.67% |
| 2012 Q1 | 144.81 Million CNY | 21.7% |
| 2011 Q2 | 120.74 Million CNY | 35.41% |
| 2011 Q4 | 118.99 Million CNY | -18.66% |
| 2011 Q1 | 89.16 Million CNY | -8.54% |
| 2011 FY | 475.21 Million CNY | 38.57% |
| 2011 Q3 | 146.3 Million CNY | 21.17% |
| 2010 Q1 | 64.12 Million CNY | 0.0% |
| 2010 Q2 | 83.71 Million CNY | 30.56% |
| 2010 Q4 | 97.49 Million CNY | -0.11% |
| 2010 FY | 342.93 Million CNY | 39.83% |
| 2010 Q3 | 97.6 Million CNY | 16.58% |
| 2009 FY | 245.25 Million CNY | 53.88% |
| 2008 FY | 159.38 Million CNY | 72.32% |
| 2007 FY | 92.49 Million CNY | 167.66% |
| 2006 FY | 34.55 Million CNY | 0.0% |